BMS-986012 in Relapsed/Refractory SCLC

Clinical trial NCT02247349 · COMPLETED

Trial details

NCT number: NCT02247349
Sponsor: Bristol-Myers Squibb
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Small Cell Lung Cancer

Start date: 2014-11-14
Primary completion: 2022-12-21
Enrollment: 106

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.